These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4185036)

  • 1. A controlled clinical trial of aldactone-A in the treatment of benign prostatic hyperplasia.
    Castro JE; Griffiths HJ; Edwards DE; Shackman R
    Br J Surg; 1969 Aug; 56(8):632. PubMed ID: 4185036
    [No Abstract]   [Full Text] [Related]  

  • 2. Pills for the benign prostate. Trial designs.
    Castro JE
    Proc R Soc Med; 1972 Feb; 65(2):126-7. PubMed ID: 4117435
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy.
    Castro JE; Griffiths HJ; Edwards DE
    Br J Surg; 1971 Jul; 58(7):485-9. PubMed ID: 4104441
    [No Abstract]   [Full Text] [Related]  

  • 4. Using antiandrogen therapy in benign prostatic hypertrophy.
    Geller J; Adler EH; Albert J; Brown DW; Licudan A; Manaig E
    Geriatrics; 1977 Apr; 32(4):63-7, 71. PubMed ID: 66171
    [No Abstract]   [Full Text] [Related]  

  • 5. [Benign prostate syndrome: urinary tract symptoms can be eased with phytotherapy].
    Popa G; Hägele-Kaddour H; Walther C
    MMW Fortschr Med; 2005 Aug; 147(33-34):42. PubMed ID: 16138635
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution of the PCPT trial to finasteride treatment of micturition disorders due to benign prostatic hyperplasia].
    de la Taille A
    Prog Urol; 2008 Apr; 18 Suppl 3():S53-7. PubMed ID: 18455085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical treatment of fibroadenomatous hypertrophy of the prostate with a new plant substance].
    Maver A
    Minerva Med; 1972 May; 63(37):2126-36. PubMed ID: 4113157
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV
    Urologiia; 2005; (5):25-6. PubMed ID: 16281835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2000; (2):3-5. PubMed ID: 11186726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough treatment for prostate enlargement.
    Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of benign prostatic hypertrophy with medrogestone.
    Rangno RE; McLeod PJ; Ruedy J; Ogilvie RI
    Clin Pharmacol Ther; 1971; 12(4):658-65. PubMed ID: 4105445
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynamic variables: novel and perhaps better predictors of progression in benign prostatic hyperplasia.
    Armitage JN; Emberton M
    BJU Int; 2006 Mar; 97(3):439-41. PubMed ID: 16469003
    [No Abstract]   [Full Text] [Related]  

  • 14. [The objective of medical treatment: relieve the symptoms or stop the course?].
    Desgrandchamps F
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():14-6. PubMed ID: 16649585
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gestonorone therapy of prostatic adenoma].
    Lopatkin N; Darenkow A; Sahmatow J; Tankó A; Ignaschin N; Warentsow G
    Acta Chir Acad Sci Hung; 1980; 21(4):271-8. PubMed ID: 6175122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.
    Crawford ED
    BJU Int; 2005 Jun; 95 Suppl 4():1-5. PubMed ID: 15871729
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report.
    Wolf H; Madsen PO
    J Urol; 1968 Jun; 99(6):780-5. PubMed ID: 4172531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.